Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$282M Buy
9,135,854
+300,111
+3% +$9.16M 0.93% 18
2016
Q3
$284M Buy
8,835,743
+104,947
+1% +$3.51M 0.97% 16
2016
Q2
$292M Buy
8,730,796
+123,593
+1% +$3.94M 1.05% 15
2016
Q1
$242M Sell
8,607,203
-591,892
-6% -$16.9M 0.9% 17
2015
Q4
$282M Buy
9,199,095
+682,876
+8% +$21.5M 1.05% 13
2015
Q3
$254M Buy
8,516,219
+719,270
+9% +$23.1M 1.02% 12
2015
Q2
$248M Sell
7,796,949
-460,000
-6% -$15M 0.96% 12
2015
Q1
$273M Sell
8,256,949
-1,182,797
-13% -$37.6M 1.09% 10
2014
Q4
$279M Buy
9,439,746
+613,885
+7% +$17.6M 1.07% 12
2014
Q3
$248M Buy
8,825,861
+487,295
+6% +$13.7M 1.07% 13
2014
Q2
$235M Buy
8,338,566
+567,772
+7% +$16.2M 1.07% 12
2014
Q1
$237M Sell
7,770,794
-412,392
-5% -$12.3M 1.06% 12
2013
Q4
$238M Sell
8,183,186
-1,025,112
-11% -$29.8M 1.06% 12
2013
Q3
$251M Sell
9,208,298
-288,454
-3% -$7.85M 1.19% 10
2013
Q2
$252M Buy
+9,496,752
New +$262M 1.16% 13

Other funds holding PFE

BlackRock Japan's PFE Position: Q4 2016 in Review

BlackRock Japan increased its Pfizer (PFE) stake by 3.4% in Q4 2016, buying an estimated $9.16M and bringing the position to 9,135,854 shares worth $282M. The position accounts for 0.93% of the portfolio, ranked #18.

BlackRock Japan first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $292M in Q2 2016. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • BlackRock Japan held 9,135,854 shares of Pfizer worth $282M as of Q4 2016.
  • BlackRock Japan bought 300,111 Pfizer shares in Q4 2016, an estimated $9.16M.
  • Pfizer made up 0.93% of BlackRock Japan's portfolio in Q4 2016, its #18 holding.
  • BlackRock Japan first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's Pfizer position peaked at $292M in Q2 2016.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.